Evidence for the reliability and preliminary validity of the Adult ADHD Self‐Report Scale v1.1 (ASRS v1.1) Screener in an adolescent community sample
Objectives There is a need for brief and publicly‐available assessments of attention deficit hyperactivity disorder (ADHD) easily administered in large‐scale survey efforts monitoring symptoms among adolescents. The ADHD Self‐Report Scale v1.1 (ASRS; Kessler et al., 2005) Screener, a six‐item measur...
Saved in:
Published in | International journal of methods in psychiatric research Vol. 28; no. 1; pp. e1751 - n/a |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.03.2019
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objectives
There is a need for brief and publicly‐available assessments of attention deficit hyperactivity disorder (ADHD) easily administered in large‐scale survey efforts monitoring symptoms among adolescents. The ADHD Self‐Report Scale v1.1 (ASRS; Kessler et al., 2005) Screener, a six‐item measure of ADHD symptoms, is a valid and reliable screening instrument for ADHD among adults. The current study provides initial evidence for the reliability and validity of the ASRS Screener among a community sample of U.S. adolescents.
Methods
Middle and high school students in grades 6 through 12 (N = 2,472) completed the ASRS Screener, along with the Strengths and Difficulties Questionnaire (SDQ; Goodman, 2001) and several questions about school functioning.
Results
The ASRS Screener demonstrated good internal consistency, with items captured by a single underlying latent variable, which was invariant across subsamples differing by gender. The ASRS Screener scores were associated with the SDQ subscale measuring hyperactivity/inattention (r = 0.58) and significantly less strongly associated with other SDQ subscale scores (r = −0.15–0.41). The ASRS Screener scores were also significantly associated with student‐reported school functioning.
Conclusion
Findings suggest directions for future research and provide preliminary support for use of the ASRS Screener as a brief tool for identifying symptoms of ADHD among adolescents. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Dr. Adler received grant and research support in the past year from Sunovion Pharmaceuticals, Enzymotec, Shire Pharmaceuticals, and Lundbeck; served as a consultant for Sunovion Pharmaceuticals, Shire Pharmaceuticals, Otsuka Pharmaceuticals, Bracket, National Football League, and Major League Baseball; and has received royalty payments (as inventor) from New York University for license of adult attention‐deficit/hyperactivity disorder (ADHD) scales and training materials since 2004. |
ISSN: | 1049-8931 1557-0657 1557-0657 |
DOI: | 10.1002/mpr.1751 |